Digestive Diseases and Sciences

, Volume 45, Issue 7, pp 1366–1375 | Cite as

Interaction Between NSAIDs and Steroid in Rat Stomach

  • Hirofumi Kataoka
  • Yukiko Horie
  • Rika Koyama
  • Seiichi Nakatsugi
  • Masumi Furukawa


The relative risk of development of peptic ulcer with the use of nonsteroidal antiinflammatory drugs (NSAIDs) has been reported to increase when these drugs are administered in combination with steroids. We investigated the ulcerogenic potential of a combination of NSAIDs and steroids in rats and the underlying pathogenic mechanisms. Indomethacin alone produced gastric lesions, and the severity of the lesions markedly increased with concomitant administration of prednisolone. However, nimesulide, even in excessive doses, did not produce any gastric lesions, regardless of concomitant administration with prednisolone. Furthermore, we showed that the ulcerogenic potential of indomethacin administered in combination with prednisolone may be related to the induction of physiological changes, such as endogenous prostaglandin deficiency, an increase in neutrophil activation, and gastric hypermotility, by indomethacin and alteration of normal epithelial renewal by the steroid. These results suggest that the ulcerogenic potential of preferential a COX-1 inhibitor increases following concomitant administration with a steroid, whereas, nimesulide, a preferential COX-2 inhibitor, is nonulcerogenic, even when administered concomitantly with a steroid, and is therefore a clinically useful antiinflammatory agent.

NSAIDs nimesulide steroid cyclooxgenase drug interaction gastric lesion 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Xie WL, Chipman JG, Robertson DL, Erikson RL, Simmons DL: Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 88:2692–2696, 1991Google Scholar
  2. 2.
    Kujubu DA, Fletcher BS, Varnum BC, Lim RW, Herschman HR: TIS 10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 266:12866–12872, 1991Google Scholar
  3. 3.
    DeWitt DL: Prostaglandin endoperoxide synthase: Regulation of enzyme expression. Biochim Biophys Acta 1083:121–134, 1991Google Scholar
  4. 4.
    Meade EA, Smith WL, DeWitt DL: Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem 268:6610–6614, 1993Google Scholar
  5. 5.
    Laneuville O, Breuer DK, Dewitt DL, Hla T, Funk CD, Smith WL: Differential inhibition of human prostaglandin endoperoxide H synthases-1 and-2 by nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther 271:927–934, 1994Google Scholar
  6. 6.
    Frolich JC: Prostaglandin endoperoxide synthetase isoenzymes: The clinical relevance of selective inhibition. Ann Rheum Dis 54:942–943, 1995Google Scholar
  7. 7.
    Lanza FL: Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin, and other nonsteroidal anti-inflammatory agents. Am J Med 77:19–24, 1984Google Scholar
  8. 8.
    Rainsford KD: An analysis of the gastro-intestinal side-effects of nonsteroidal anti-inflammatory drugs, with particular reference to comparative studies in man and laboratory species. Rheumatol Int 2:1–10, 1982Google Scholar
  9. 9.
    Wagner KA, Nandi J, King RL, Levine RA: Effects of nonsteroidal antiinflammatory drugs on ulcerogenesis and gastric secretion in pylorus-ligated rat. Dig Dis Sci 40:134–140, 1995Google Scholar
  10. 10.
    Futaki N, Yoshikawa K, Hamasaka Y, Arai I, Higuchi S, Iizuka H, Otomo S: NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions. Gen Pharmacol 24:105–110, 1993Google Scholar
  11. 11.
    Chan CC, Boyce S, Brideau C, Ford Hutchinson AW, Gordon R, Guay D, Hill RG, Li CS, Mancini J, Penneton M, Prasit P, Rasori R, Riendeau D, Roy P, Tagari P, Vickers P, Wong E, Rodger IW: Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: A novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach. J Pharmacol Exp Ther 274:1531–1537, 1995Google Scholar
  12. 12.
    Nakatsugi S, Terada N, Yoshimura T, Horie Y, Furukawa M: Effects of nimesulide, a preferential cyclooxygenase-2 inhibitor, on carrageenan-induced pleurisy and stress-induced gastric lesions in rats. Prostaglandins Leukot Essent Fatty Acids 55:395–402, 1996Google Scholar
  13. 13.
    Messer J, Reitman D, Sacks HS, Smith H Jr, Chalmers TC: Association of adrenocorticosteroid therapy and peptic-ulcer disease. N Engl J Med 309:21–24, 1983Google Scholar
  14. 14.
    Robert A, Nezxmis JE: Histopathology of steroid-induced ulcers. Arch Pathol 77:407–423, 1964Google Scholar
  15. 15.
    Gabriel SE, Jaakkimainen L, Bombardier C: Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med 115:787–796, 1991Google Scholar
  16. 16.
    Nobuhara Y, Takeuchi K, Okabe S: Effects of various agents on prednisolone-induced gastric lesions in rats. Jpn J Pharmacol 38:219–222, 1985Google Scholar
  17. 17.
    Kobayashi K, Arakawa T, Satoh H, Fukuda T, Nakamura H: Effect of indomethacin, tiaprofenic acid and dicrofenac on rat gastric mucosal damage and content of prostacyclin and prostaglandin E2. Prostaglandins 30:609–618, 1985Google Scholar
  18. 18.
    Powell WS: Rapid extraction of oxygenated metabolites of arachidonic acid from biological samples using octadecylsilyl silica. Prostaglandins 20:947–957, 1980Google Scholar
  19. 19.
    Santucci L, Fiorucci S, Di Matteo FM, Morelli A: Role of tumor necrosis factor alpha release and leukocyte margination in indomethacin-induced gastric injury in rats. Gastroenterology 108:393–401, 1995Google Scholar
  20. 20.
    Ueki S, Takeuchi K, Okabe S: Gastric motility is an important factor in the pathogenesis of indomethacin-induced gastric mucosal lesions in rats. Dig Dis Sci 33:209–216, 1988Google Scholar
  21. 21.
    Takeuchi K, Johnson LR: Pentagastrin protects against stress ulceration in rats. Gastroenterology 76:327–334, 1979Google Scholar
  22. 22.
    Shorrock CJ, Rees WD: Mucosal adaptation to indomethacin induced gastric damage in man-studies on morphology, blood flow, and prostaglandin E2 metabolism. Gut 33:164–169, 1992Google Scholar
  23. 23.
    Lippmann W: Inhibition of indomethacin-induced gastric ulceration in the rat by perorally-administered synthetic and natural prostaglandin analogues. Prostaglandins 7:1–10, 1974Google Scholar
  24. 24.
    Whittle BJ: Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology 80:94–98, 1981Google Scholar
  25. 25.
    Wallace JL: Prostaglandins, NSAIDs, and cytoprotection. Gastroenterol Clin North Am 21:631–641, 1992Google Scholar
  26. 26.
    Masferrer JL, Zweifel BS, Manning PT, Hauser SD, Leahy KM, Smith WG, Isakson PC, Seibert K: Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and non-ulcerogenic. Proc Natl Acad Sci USA 91:3228–3232, 1994Google Scholar
  27. 27.
    Okada M, Niida H, Takeuchi K, Okabe S: Role of prostaglandin deficiency in pathogenetic mechanism of gastric lesions induced by indomethacin in rats. Dig Dis Sci 34:694–702, 1989Google Scholar
  28. 28.
    Takeuchi K, Kato S, Nishiwaki H, Hirata T: Analysis of pathogenic elements involved in gastric lesions induced by nonsteroidal anti-inflammatory drugs in rats. J Gastroenterol Hepatol 12:360–367, 1997Google Scholar
  29. 29.
    Elliott SL, Ferris RJ, Giraud AS, Cook GA, Skeljo MV, Yeomans ND: Indomethacin damage to rat gastric mucosa is markedly dependent on luminal pH. Clin Exp Pharmacol Physiol 23:432–434, 1996Google Scholar
  30. 30.
    Wallace JL, Keenan CM, Granger DN: Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil-dependent process. Am J Physiol 259:G462-G467, 1990Google Scholar
  31. 31.
    Takeuchi K, Ueki S, Okabe S: Importance of gastric motility in the pathogenesis of indomethacin-induced gastric lesions in rats. Dig Dis Sci 31:1114–1122, 1986Google Scholar
  32. 32.
    Eastwood GL, Quimby GF, Bonnice CA, Kuwayama H: Inhibition of human gastric epithelial proliferation by prednisone. Gastroenterology 82:1048, 1982Google Scholar
  33. 33.
    Eastwood GL, Quimby GF, Laferriere JR: Effects of chronic steroid ingestion on gastroduodenal epithelial renewal in the rat. Cell Tissue Kinet 14:405–411, 1981Google Scholar
  34. 34.
    Kuwayama H, Eastwood GL: Effects of parenteral hydrocortisone sodium succinate on epithelial renewal in hamster gastric mucosa. Dig Dis Sci 33:1064–1069, 1988Google Scholar

Copyright information

© Plenum Publishing Corporation 2000

Authors and Affiliations

  • Hirofumi Kataoka
    • 1
  • Yukiko Horie
    • 1
  • Rika Koyama
    • 1
  • Seiichi Nakatsugi
    • 1
  • Masumi Furukawa
    • 1
  1. 1.Osaka Research LaboratorySawai Pharmaceutical Co., LTD.OsakaJapan

Personalised recommendations